# Baker Brothers Q2 2026 13F: holdings and trades

URL: https://funkfolio.com/gurus/baker-brothers/2026-q2

> Baker Brothers's Q2 2026 13F: Baker Bros. Advisors reported $20B in 84 positions, led by INCY, ONC. Every holding, and what was bought and sold that quarter.

---

## Baker Brothers portfolio, Q2 2026

Baker Bros. Advisors · 13F for the quarter ending Jun 30, 2026

For Q2 2026, Baker Bros. Advisors reported $20B across 84 US-listed positions, led by INCY (17.5%), ONC (12.6%) and RVMD (10.7%). Compared with its filing for Q1 2026, Baker Brothers opened 8 new positions, added to 16, reduced 7 and sold out of 8; 52 positions did not change.

The largest purchase was an addition to RVMD ($353.6M); the largest sale, a reduction of EWTX ($116.8M).

This is the latest filing on file; the [main portfolio page](https://funkfolio.com/gurus/baker-brothers) shows the same holdings against today's prices.

**Reported value:** $20B

**Positions:** 84

**In the top 10:** 73%

**Filed:** Aug 14 2026

### Key facts

- **13F portfolio value:** $20B Q2 2026
- **Positions:** 84
- **Largest holding:** INCY 17.5%
- **New positions:** 8
- **Sold out:** 8
- **Filed:** Aug 14, 2026

Holdings as of Jun 30, 2026 (Q2 2026), filed with the SEC on Aug 14, 2026. Changes are measured against the filing for Mar 31, 2026. [Every tracked investor's Q2 2026 13F](https://funkfolio.com/gurus/quarter/2026-q2).

### Bought and sold in Q2 2026

Baker Brothers: buys and sells in Q2 2026

| Stock | Move | Shares | Size | Of portfolio |
| --- | --- | --- | --- | --- |
| [Revolution Medicines Inc RVMD](https://funkfolio.com/stock/RVMD) | ▲ Added 20% | +1.89M | $353.6M | 1.77% |
| [Insmed Inc INSM](https://funkfolio.com/stock/INSM) | ▲ Added 19% | +1.38M | $146.6M | 0.73% |
| [Edgewise Therapeutics Inc EWTX](https://funkfolio.com/stock/EWTX) | ▼ Reduced 44% | −2.87M | $116.8M | 0.59% |
| [Abivax SA ABVX](https://funkfolio.com/stock/ABVX) | ▼ Sold out | −875.8K | $97.5M | 0.49% |
| [Summit Therapeutics Inc SMMT](https://funkfolio.com/stock/SMMT) | ▼ Reduced 9.9% | −3.6M | $52.5M | 0.26% |
| [Spyre Therapeutics Inc SYRE](https://funkfolio.com/stock/SYRE) | ▼ Sold out | −1M | $50.4M | 0.25% |
| [IDEAYA Biosciences Inc IDYA](https://funkfolio.com/stock/IDYA) | ▲ Added 27% | +1.06M | $39.6M | 0.20% |
| [Faeth Therapeutics Inc FTH](https://funkfolio.com/stock/FTH) | ▲ New | +1.29M | $32.2M | 0.16% |
| [Relay Therapeutics Inc RLAY](https://funkfolio.com/stock/RLAY) | ▲ Added 144% | +1.67M | $31.2M | 0.16% |
| Centessa Pharmaceuticals PLC no ticker on file | ▼ Sold out | −670.75K | $26.6M | 0.13% |
| [Immunocore Holdings plc IMCR](https://funkfolio.com/stock/IMCR) | ▼ Sold out | −734.4K | $22.1M | 0.11% |
| [Abcellera Biologics Inc ABCL](https://funkfolio.com/stock/ABCL) | ▲ Added 9.0% | +2.74M | $21.5M | 0.11% |
| [Celldex Therapeutics Inc CLDX](https://funkfolio.com/stock/CLDX) | ▲ Added 78% | +517.24K | $19.2M | 0.10% |
| [Contineum Therapeutics Inc CTNM](https://funkfolio.com/stock/CTNM) | ▼ Sold out | −1.42M | $18.6M | 0.09% |
| [argenx SE ARGX](https://funkfolio.com/stock/ARGX) | ▼ Sold out | −25.17K | $18.4M | 0.09% |
| [Cytokinetics Inc CYTK](https://funkfolio.com/stock/CYTK) | ▲ New | +211.27K | $18M | 0.09% |
| [Intellia Therapeutics Inc NTLA](https://funkfolio.com/stock/NTLA) | ▲ New | +930.23K | $15.7M | 0.08% |
| [Immatics N.V. IMTX](https://funkfolio.com/stock/IMTX) | ▼ Reduced 13% | −1.41M | $14.3M | 0.07% |
| [Parabilis Medicines Inc PBLS](https://funkfolio.com/stock/PBLS) | ▲ New | +500K | $13.7M | 0.07% |
| [Arcus Biosciences Inc RCUS](https://funkfolio.com/stock/RCUS) | ▲ Added 103% | +429.2K | $13.2M | 0.07% |
| [Compass Pathways Plc CMPS](https://funkfolio.com/stock/CMPS) | ▼ Sold out | −2.34M | $13M | 0.06% |
| [Avalyn Pharma Inc AVLN](https://funkfolio.com/stock/AVLN) | ▲ New | +350K | $11.5M | 0.06% |
| [Pharvaris N V PHVS](https://funkfolio.com/stock/PHVS) | ▼ Sold out | −375K | $10.6M | 0.05% |
| [Cerus Corp CERS](https://funkfolio.com/stock/CERS) | ▼ Reduced 36% | −3.61M | $10.5M | 0.05% |
| [Tango Therapeutics Inc TNGX](https://funkfolio.com/stock/TNGX) | ▲ New | +333.33K | $10.4M | 0.05% |
| [Avalo Therapeutics Inc AVTX](https://funkfolio.com/stock/AVTX) | ▲ New | +550K | $10.2M | 0.05% |
| [Jade Biosciences Inc JBIO](https://funkfolio.com/stock/JBIO) | ▼ Reduced 25% | −410.71K | $9.1M | 0.05% |
| [Viridian Therapeutics Inc VRDN](https://funkfolio.com/stock/VRDN) | ▲ Added 21% | +411.35K | $7.6M | 0.04% |
| [Verastem Inc VSTM](https://funkfolio.com/stock/VSTM) | ▲ Added 327% | +1.91M | $7.3M | 0.04% |
| [Roivant Sciences Ltd ROIV](https://funkfolio.com/stock/ROIV) | ▼ Reduced 3.1% | −150.89K | $5.3M | 0.03% |
| [Incyte Corp INCY](https://funkfolio.com/stock/INCY) | ▲ Added 0.06% | +17.92K | $2M | 0.01% |
| [Design Therapeutics Inc DSGN](https://funkfolio.com/stock/DSGN) | ▲ Added 3.6% | +92.45K | $1.3M | 0.01% |
| [Immunome Inc IMNM](https://funkfolio.com/stock/IMNM) | ▲ New | +55.31K | $1.2M | 0.01% |
| [Immunovant Inc IMVT](https://funkfolio.com/stock/IMVT) | ▼ Reduced 0.4% | −22.66K | $873.1K | 0.00% |
| [Madrigal Pharmaceuticals Inc MDGL](https://funkfolio.com/stock/MDGL) | ▲ Added 0.07% | +1.43K | $767.8K | 0.00% |
| [Beone Medicines Ltd ONC](https://funkfolio.com/stock/ONC) | ▲ Added 0.03% | +2.51K | $716.4K | 0.00% |
| [Kiniksa Pharmaceuticals International KNSA](https://funkfolio.com/stock/KNSA) | ▲ Added 0.3% | +8.4K | $537K | 0.00% |
| [Acadia Pharmaceuticals Inc ACAD](https://funkfolio.com/stock/ACAD) | ▲ Added 0.04% | +16.21K | $410.2K | 0.00% |
| [Denali Therapeutics Inc DNLI](https://funkfolio.com/stock/DNLI) | ▲ Added 0.07% | +2.64K | $67.9K | 0.00% |

### Holdings at the quarter's end

Baker Brothers holdings, Q2 2026

| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q1 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | [Incyte Corp INCY](https://funkfolio.com/stock/INCY) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 17.5% | $3.5B | 30.76M | $113.36 | 9+ qtrs | ▲ Added 0.06% |
| 2 | [Beone Medicines Ltd ONC · SPONSORED ADS](https://funkfolio.com/stock/ONC) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 12.6% | $2.5B | 8.8M | $284.97 | 9+ qtrs | ▲ Added 0.03% |
| 3 | [Revolution Medicines Inc RVMD](https://funkfolio.com/stock/RVMD) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 10.7% | $2.1B | 11.44M | $187.28 | 9+ qtrs | ▲ Added 20% |
| 4 | [Madrigal Pharmaceuticals Inc MDGL](https://funkfolio.com/stock/MDGL) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 5.77% | $1.2B | 2.14M | $536.95 | 9+ qtrs | ▲ Added 0.07% |
| 5 | [Acadia Pharmaceuticals Inc ACAD](https://funkfolio.com/stock/ACAD) | — | 5.44% | $1.1B | 42.91M | $25.30 | 9+ qtrs | ▲ Added 0.04% |
| 6 | [Kymera Therapeutics Inc KYMR](https://funkfolio.com/stock/KYMR) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 4.98% | $992.7M | 8.66M | $114.67 | 9+ qtrs | No change |
| 7 | [Insmed Inc INSM](https://funkfolio.com/stock/INSM) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 4.70% | $937.8M | 8.8M | $106.62 | 9+ qtrs | ▲ Added 19% |
| 8 | [Celcuity Inc CELC](https://funkfolio.com/stock/CELC) | — | 4.15% | $828.2M | 7.92M | $104.62 | 9+ qtrs | No change |
| 9 | [Kodiak Sciences Inc KOD](https://funkfolio.com/stock/KOD) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 3.89% | $776.1M | 19.92M | $38.96 | 9+ qtrs | No change |
| 10 | [Rhythm Pharmaceuticals Inc RYTM](https://funkfolio.com/stock/RYTM) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 3.12% | $622.3M | 5.6M | $111.03 | 9+ qtrs | No change |
| 11 | [Praxis Precision Medicines PRAX](https://funkfolio.com/stock/PRAX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 2.94% | $587M | 1.75M | $334.79 | 9+ qtrs | No change |
| 12 | [Alkermes PLC ALKS · SHS](https://funkfolio.com/stock/ALKS) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 2.63% | $524.6M | 10.01M | $52.39 | 9+ qtrs | No change |
| 13 | [Summit Therapeutics Inc SMMT](https://funkfolio.com/stock/SMMT) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 2.39% | $477.7M | 32.79M | $14.57 | 9+ qtrs | ▼ Reduced 9.9% |
| 14 | [Grail Inc GRAL](https://funkfolio.com/stock/GRAL) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 1.38% | $275M | 4.03M | $68.27 | 7 qtrs | No change |
| 15 | [Abcellera Biologics Inc ABCL](https://funkfolio.com/stock/ABCL) | — | 1.30% | $259.1M | 33.01M | $7.85 | 9+ qtrs | ▲ Added 9.0% |
| 16 | [Immunovant Inc IMVT](https://funkfolio.com/stock/IMVT) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 1.05% | $209.4M | 5.44M | $38.53 | 9+ qtrs | ▼ Reduced 0.4% |
| 17 | [IDEAYA Biosciences Inc IDYA](https://funkfolio.com/stock/IDYA) | — | 0.94% | $186.7M | 5.01M | $37.27 | 9+ qtrs | ▲ Added 27% |
| 18 | [Kiniksa Pharmaceuticals International KNSA · ORD SHS CL A](https://funkfolio.com/stock/KNSA) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.91% | $181.3M | 2.83M | $63.95 | 9+ qtrs | ▲ Added 0.3% |
| 19 | [Roivant Sciences Ltd ROIV · SHS](https://funkfolio.com/stock/ROIV) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.84% | $166.9M | 4.72M | $35.39 | 9+ qtrs | ▼ Reduced 3.1% |
| 20 | [Arrowhead Pharmaceuticals ARWR](https://funkfolio.com/stock/ARWR) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.81% | $162.4M | 1.99M | $81.51 | 5 qtrs | No change |
| 21 | [Ionis Pharmaceuticals Inc IONS](https://funkfolio.com/stock/IONS) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.81% | $162.4M | 2.05M | $79.29 | 4 qtrs | No change |
| 22 | [Edgewise Therapeutics Inc EWTX](https://funkfolio.com/stock/EWTX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.75% | $150.4M | 3.7M | $40.63 | 9+ qtrs | ▼ Reduced 44% |
| 23 | [Replimune Group Inc REPL](https://funkfolio.com/stock/REPL) | — | 0.61% | $122.3M | 11.05M | $11.07 | 9+ qtrs | No change |
| 24 | [Nurix Therapeutics Inc NRIX](https://funkfolio.com/stock/NRIX) | — | 0.57% | $113M | 4.66M | $24.26 | 9+ qtrs | No change |
| 25 | [Stoke Therapeutics Inc STOK](https://funkfolio.com/stock/STOK) | — | 0.55% | $109.2M | 3.34M | $32.72 | 9+ qtrs | No change |
| 26 | [Monte Rosa Therapeutics Inc GLUE](https://funkfolio.com/stock/GLUE) | — | 0.53% | $105.2M | 4.35M | $24.20 | 9+ qtrs | No change |
| 27 | [Immatics N.V. IMTX · SHS](https://funkfolio.com/stock/IMTX) | — | 0.48% | $96.3M | 9.51M | $10.13 | 9+ qtrs | ▼ Reduced 13% |
| 28 | [Denali Therapeutics Inc DNLI](https://funkfolio.com/stock/DNLI) | — | 0.48% | $96M | 3.73M | $25.72 | 9+ qtrs | ▲ Added 0.07% |
| 29 | Crinetics Pharmaceuticals no ticker on file | — | 0.44% | $88M | 2.35M | $37.42 | 5 qtrs | No change |
| 30 | [Dianthus Therapeutics Inc DNTH](https://funkfolio.com/stock/DNTH) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.42% | $83.1M | 852.16K | $97.48 | 5 qtrs | No change |
| 31 | [Structure Therapeutics Inc GPCR · SPONSORED ADS](https://funkfolio.com/stock/GPCR) | — | 0.39% | $76.9M | 1.43M | $53.67 | 8 qtrs | No change |
| 32 | Celcuity Inc no ticker on file · NOTE 2.75% 8/1/2031 | — | 0.35% | $69.2M | — | — | 4 qtrs | — |
| 33 | [Rapport Therapeutics Inc RAPP](https://funkfolio.com/stock/RAPP) | — | 0.32% | $64.5M | 1.55M | $41.67 | 5 qtrs | No change |
| 34 | [Alumis Inc ALMS](https://funkfolio.com/stock/ALMS) | — | 0.28% | $56.6M | 2.01M | $28.14 | 9+ qtrs | No change |
| 35 | [Prelude Therapeutics Inc PRLD](https://funkfolio.com/stock/PRLD) | — | 0.27% | $54M | 10.12M | $5.33 | 9+ qtrs | No change |
| 36 | [Relay Therapeutics Inc RLAY](https://funkfolio.com/stock/RLAY) | — | 0.27% | $52.9M | 2.83M | $18.71 | 9+ qtrs | ▲ Added 144% |
| 37 | [Mirum Pharmaceuticals Inc MIRM](https://funkfolio.com/stock/MIRM) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.26% | $52.2M | 445.98K | $117.07 | 2 qtrs | No change |
| 38 | [Bicycle Therapeutics Plc BCYC · SPONSORED ADS](https://funkfolio.com/stock/BCYC) | — | 0.23% | $46.2M | 10.89M | $4.24 | 9+ qtrs | No change |
| 39 | [Enliven Therapeutics Inc ELVN](https://funkfolio.com/stock/ELVN) | — | 0.23% | $45.9M | 905.19K | $50.75 | 9+ qtrs | No change |
| 40 | [Celldex Therapeutics Inc CLDX](https://funkfolio.com/stock/CLDX) | — | 0.22% | $44M | 1.18M | $37.21 | 9+ qtrs | ▲ Added 78% |
| 41 | [Viridian Therapeutics Inc VRDN](https://funkfolio.com/stock/VRDN) | — | 0.22% | $43.8M | 2.38M | $18.37 | 5 qtrs | ▲ Added 21% |
| 42 | [Design Therapeutics Inc DSGN](https://funkfolio.com/stock/DSGN) | — | 0.19% | $38.8M | 2.68M | $14.47 | 9+ qtrs | ▲ Added 3.6% |
| 43 | [Entrada Therapeutics Inc TRDA](https://funkfolio.com/stock/TRDA) | — | 0.19% | $37.3M | 5.07M | $7.36 | 9+ qtrs | No change |
| 44 | [Faeth Therapeutics Inc FTH](https://funkfolio.com/stock/FTH) | — | 0.16% | $32.2M | 1.29M | $25.00 | 1 qtr | New |
| 45 | [Aktis Oncology Inc AKTS](https://funkfolio.com/stock/AKTS) | — | 0.16% | $32.1M | 996.35K | $32.23 | 2 qtrs | No change |
| 46 | [Neurogene Inc NGNE](https://funkfolio.com/stock/NGNE) | — | 0.16% | $31.2M | 991.69K | $31.45 | 9+ qtrs | No change |
| 47 | [Jade Biosciences Inc JBIO](https://funkfolio.com/stock/JBIO) | — | 0.14% | $27.3M | 1.23M | $22.22 | 3 qtrs | ▼ Reduced 25% |
| 48 | [Taysha Gene Therapies Inc TSHA](https://funkfolio.com/stock/TSHA) | — | 0.14% | $27.3M | 4M | $6.81 | 9+ qtrs | No change |
| 49 | [Arcus Biosciences Inc RCUS](https://funkfolio.com/stock/RCUS) | — | 0.13% | $26M | 844.82K | $30.83 | 3 qtrs | ▲ Added 103% |
| 50 | [Disc Medicine Inc IRON](https://funkfolio.com/stock/IRON) | — | 0.13% | $25.6M | 349.66K | $73.14 | 7 qtrs | No change |
| 51 | [Absci Corp ABSI](https://funkfolio.com/stock/ABSI) | — | 0.12% | $24.7M | 2.13M | $11.59 | 3 qtrs | No change |
| 52 | [Generate Biomedicines Inc GENB](https://funkfolio.com/stock/GENB) | — | 0.12% | $24M | 1.42M | $16.87 | 2 qtrs | No change |
| 53 | [Dbv Technologies S A Sponsored DBVT · SPONSORED ADS](https://funkfolio.com/stock/DBVT) | — | 0.12% | $24M | 1.46M | $16.40 | 9+ qtrs | No change |
| 54 | [Xenon Pharmaceuticals Inc XENE](https://funkfolio.com/stock/XENE) | — | 0.11% | $22.3M | 370.21K | $60.36 | 9+ qtrs | No change |
| 55 | [Tectonic Therapeutic Inc TECX](https://funkfolio.com/stock/TECX) | — | 0.11% | $20.9M | 607.79K | $34.38 | 6 qtrs | No change |
| 56 | [Cerus Corp CERS](https://funkfolio.com/stock/CERS) | — | 0.09% | $18.7M | 6.4M | $2.92 | 9+ qtrs | ▼ Reduced 36% |
| 57 | [CytomX Therapeutics Inc CTMX](https://funkfolio.com/stock/CTMX) | — | 0.09% | $18.7M | 4.98M | $3.75 | 5 qtrs | No change |
| 58 | [Dyne Therapeutics Inc DYN](https://funkfolio.com/stock/DYN) | — | 0.09% | $18.1M | 813.45K | $22.21 | 3 qtrs | No change |
| 59 | [Cytokinetics Inc CYTK](https://funkfolio.com/stock/CYTK) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.09% | $18M | 211.27K | $85.19 | 1 qtr | New |
| 60 | [Xencor Inc XNCR](https://funkfolio.com/stock/XNCR) | — | 0.09% | $17.7M | 1.1M | $16.10 | 9+ qtrs | No change |
| 61 | [Sionna Therapeutics Inc SION](https://funkfolio.com/stock/SION) | — | 0.09% | $17.6M | 400K | $43.99 | 6 qtrs | No change |
| 62 | [Intellia Therapeutics Inc NTLA](https://funkfolio.com/stock/NTLA) | — | 0.08% | $15.7M | 930.23K | $16.92 | 1 qtr | New |
| 63 | [Parabilis Medicines Inc PBLS](https://funkfolio.com/stock/PBLS) | — | 0.07% | $13.7M | 500K | $27.37 | 1 qtr | New |
| 64 | [Maplight Therapeutics Inc MPLT](https://funkfolio.com/stock/MPLT) | — | 0.07% | $13.1M | 364.71K | $35.84 | 3 qtrs | No change |
| 65 | [Avalyn Pharma Inc AVLN](https://funkfolio.com/stock/AVLN) | — | 0.06% | $11.5M | 350K | $32.92 | 1 qtr | New |
| 66 | [Evommune Inc EVMN](https://funkfolio.com/stock/EVMN) | — | 0.06% | $11.3M | 847.39K | $13.29 | 2 qtrs | No change |
| 67 | [BioNTech SE BNTX · SPONSORED ADS](https://funkfolio.com/stock/BNTX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.06% | $11.1M | 119.74K | $93.05 | 7 qtrs | No change |
| 68 | [Tango Therapeutics Inc TNGX](https://funkfolio.com/stock/TNGX) | — | 0.05% | $10.4M | 333.33K | $31.26 | 1 qtr | New |
| 69 | [Avalo Therapeutics Inc AVTX](https://funkfolio.com/stock/AVTX) | — | 0.05% | $10.2M | 550K | $18.48 | 1 qtr | New |
| 70 | [Sera Prognostics Inc SERA · CLASS A COM](https://funkfolio.com/stock/SERA) | — | 0.05% | $10M | 5.5M | $1.82 | 9+ qtrs | No change |
| 71 | [Verastem Inc VSTM](https://funkfolio.com/stock/VSTM) | — | 0.05% | $9.5M | 2.5M | $3.82 | 2 qtrs | ▲ Added 327% |
| 72 | [Sagimet Biosciences Inc SGMT](https://funkfolio.com/stock/SGMT) | — | 0.04% | $7.4M | 953K | $7.73 | 9+ qtrs | No change |
| 73 | [Eikon Therapeutics Inc EIKN](https://funkfolio.com/stock/EIKN) | — | 0.04% | $7.2M | 555.56K | $13.05 | 2 qtrs | No change |
| 74 | [LB Pharmaceuticals Inc LBRX](https://funkfolio.com/stock/LBRX) | — | 0.03% | $6.5M | 200K | $32.46 | 4 qtrs | No change |
| 75 | [vTv Therapeutics Inc VTVT · CL A](https://funkfolio.com/stock/VTVT) | — | 0.03% | $5.6M | 148.31K | $37.65 | 9+ qtrs | No change |
| 76 | [Wave Life Sciences Ltd WVE · SHS](https://funkfolio.com/stock/WVE) | — | 0.02% | $4.8M | 822.64K | $5.81 | 8 qtrs | No change |
| 77 | [Protara Therapeutics Inc TARA](https://funkfolio.com/stock/TARA) | — | 0.02% | $3.7M | 971.61K | $3.82 | 9+ qtrs | No change |
| 78 | [TScan Therapeutics Inc TCRX](https://funkfolio.com/stock/TCRX) | — | 0.01% | $2.7M | 2.78M | $0.9801 | 9+ qtrs | No change |
| 79 | [Immunome Inc IMNM](https://funkfolio.com/stock/IMNM) | — | 0.01% | $1.2M | 55.31K | $21.19 | 1 qtr | New |
| 80 | [Skye Bioscience Inc SKYE](https://funkfolio.com/stock/SKYE) | — | 0.01% | $1.1M | 1.58M | $0.6933 | 9+ qtrs | No change |
| 81 | [Sana Biotechnology Inc SANA](https://funkfolio.com/stock/SANA) | — | 0.01% | $1.1M | 310.48K | $3.49 | 9+ qtrs | No change |
| 82 | [Aligos Therapeutics Inc ALGS](https://funkfolio.com/stock/ALGS) | — | 0.00% | $479.2K | 83.06K | $5.77 | 9+ qtrs | No change |
| 83 | [Tyra Biosciences Inc TYRA](https://funkfolio.com/stock/TYRA) | — | 0.00% | $338.8K | 10.61K | $31.94 | 9+ qtrs | No change |
| 84 | Surrozen Inc no ticker on file · W EXP 8/11/2026 | — | 0.00% | $13.8K | 833.33K | $0.0165 | 9+ qtrs | No change |

### By sector

Baker Brothers portfolio by sector, Q2 2026

| Sector | Share of portfolio | Value | Positions |
| --- | --- | --- | --- |
| [Health Care](https://funkfolio.com/companies?sector=health-care) | 78.6% | $15.7B | 22 |
| No sector on file | 21.4% | $4.3B | 62 |

### Questions and answers

**What did Baker Brothers own in Q2 2026?**

Baker Bros. Advisors's 13F for Q2 2026 lists 84 positions worth $20B. The largest: INCY (17.5%), ONC (12.6%), RVMD (10.7%), MDGL (5.8%), ACAD (5.4%).

**What did Baker Brothers buy in Q2 2026?**

The largest purchases, by the shares bought at the quarter-end price the filing implies: RVMD (added, $353.6M), INSM (added, $146.6M), IDYA (added, $39.6M), FTH (new, $32.2M), RLAY (added, $31.2M), ABCL (added, $21.5M).

**What did Baker Brothers sell in Q2 2026?**

The largest sales: EWTX (reduced, $116.8M), ABVX (sold out, $97.5M), SMMT (reduced, $52.5M), SYRE (sold out, $50.4M), Centessa Pharmaceuticals PLC (sold out, $26.6M), IMCR (sold out, $22.1M).

**When was this filing made?**

Baker Bros. Advisors filed its 13F for the quarter ending Jun 30, 2026 on Aug 14, 2026. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

### Learn

- [What a 13F filing is](https://funkfolio.com/learn/superinvestors/what-is-a-13f)
- [How to read a superinvestor's portfolio](https://funkfolio.com/learn/superinvestors/how-to-read-a-13f-portfolio)
- [New, added, reduced, sold: reading 13F changes](https://funkfolio.com/learn/superinvestors/13f-changes-explained)
- [All superinvestor guides](https://funkfolio.com/learn/superinvestors)

### Cite this page

Funkfolio, “Baker Brothers portfolio, Q2 2026: Baker Bros. Advisors 13F holdings”, data as of 14 August 2026. https://funkfolio.com/gurus/baker-brothers/2026-q2

Underlying data: SEC EDGAR, Form 13F-HR of Baker Bros. Advisors (CIK 1263508) for the period ending Jun 30, 2026.

Source: SEC EDGAR, Form 13F-HR for Baker Bros. Advisors (CIK 1263508), period ending Jun 30, 2026, filed Aug 14, 2026. Changes compare share counts with the filing for Mar 31, 2026; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $20B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 9 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.
